Vascular

UK vascular device specialist Veryan Medical has developed a stent design technology which aims to mimic the helical shape of peripheral vessels in the hope that this will have a vasoprotective effect and furthermore reduce risk of deformation and vessel trauma during leg flexion.

Peripheral vascular disease treatments have shuffled under the spotlight in recent months with a seemingly endless trail of new devices and approvals for unblocking diseased vasculature. Now Cook Medical can say it has the first drug-eluting stent to be FDA approved for the job.

More good news for Biotronik’s peripheral vascular business as its Pulsar 18 study gets underway in the U.S., hot on the heels of favourable clinical study results from Europe.

Clinical study results show strong evidence of benefits for lower limb intervention when using Pulsar stents, with no statistical difference between heavily calcified and non calcified lesions.

Just over two years after it was CE marked, TriVascular’s Ovation Stent Graft, suitable for use in patients with small vascular access and challenging anatomy, has gained full approval in the United States.

J&J subsidiary, Cordis Corporation has announced that the U.S. FDA has approved its S.M.A.R.T.® CONTROL® Vascular Stent Systems for use in the superficial femoral artery and/or the proximal popliteal artery.

Well well well. All the big players have renal denervation systems in development or already in the catalogue. Now, so does Boston Scientific with the year’s least surprising acquisition of Vessix Vascular.

Data from the St.Jude EnligHTN I multi-electrode renal denervation catheter study presented at the annual scientific meeting of the American Heart Association suggests blood pressure reduction is sustained at six months.

U.S. market intelligence company Millennium Research Group has issued a new report into vascular disease trends in the Middle East and reckons obesity is a key driver for future vascular therapies in the region. Dunno why but I have an image of a supersized
American wagging his finger at a well-built Arab and calling him fat.

Blue Medical, the global medical device company and innovator in the treatment of vascular diseases, today announced receiving the CE mark for Protégé NC, a non compliant drug eluting balloon.

New Data Presented at the 24th Annual Transcatheter Cardiovascular Therapeutics Scientific Symposium Show Sustained Blood Pressure Reduction and Safety with Symplicity™ Renal Denervation System in Patients with Treatment-Resistant Hypertension

German company Cardionovum GmbH has updated us with the news that its distribution network, covering 57 countries, is pressing ahead with the commercialisation of its Primus® paclitaxel-coated balloon based on preclinical and clinical support.

Lombard Medical Technologies PLC, is confident it will jump the final hurdles as it gains written feedback from the U.S. FDA on the PMA application for Aorfix™, the Company’s flexible stent graft for the endovascular repair of abdominal aortic aneurysms.

Boston Scientific Corporation has announced the U.S. and European launch of its Victory™ guidewire, designed to facilitate crossing of resistant lesions and the placement and exchange of balloon catheters or other interventional devices within the peripheral vasculature.

Clinical study results presented this week are being touted as support for the theory that by inducing a three dimensional component into a mechanical stent, its flow characteristics will mimic the natural geometry of human vessels.

Study confirms effectiveness of directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a frontline therapy when treating PAD